GC Biopharma Corp. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported negative sales was KRW 0.00018 million compared to KRW 0.00047 million a year ago.

Net loss was KRW 26,631.78 million compared to net income of KRW 65,453.13 million a year ago. Basic loss per share from continuing operations was KRW 2,333 compared to basic earnings per share from continuing operations of KRW 5,735 a year ago. Basic loss per share was KRW 2,333 compared to basic earnings per share of KRW 5,735 a year ago.